To broaden the clinical relevance of nuclear Bcl-xL beyond PNET, we sought to determine whether nuclear Bcl-xL can also be found in specimens of breast cancer, the most common malignancy in women. The gene discussed is BCL2L1; the disease is breast carcinoma.